| MeSH term | MeSH ID | Detail |
|---|---|---|
| Malnutrition | D044342 | 6 associated lipids |
| Glucose Metabolism Disorders | D044882 | 3 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Hypertension, Pregnancy-Induced | D046110 | 2 associated lipids |
| Diabetes Complications | D048909 | 4 associated lipids |
| Hyperparathyroidism, Primary | D049950 | 1 associated lipids |
| Hashimoto Disease | D050031 | 1 associated lipids |
| Dyslipidemias | D050171 | 7 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Arteriolosclerosis | D050379 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
| Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
| Recht M et al. | The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. | 2013 | Haemophilia | pmid:23731369 |
| Wu X et al. | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. | 2013 | Eur. J. Med. Res. | pmid:23731710 |
| Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
| Rozas Moreno P et al. | Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? | 2013 | J. Endocrinol. Invest. | pmid:22391059 |
| Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
| Bezerra JP et al. | Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. | 2013 | J. Periodontol. | pmid:22873654 |
| de Matos FR et al. | Immunohistochemical detection of receptor activator nuclear κB ligand and osteoprotegerin in odontogenic cysts and tumors. | 2013 | J. Oral Maxillofac. Surg. | pmid:23992784 |
| Yabumoto T et al. | Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23992809 |
| Ghaffari S et al. | The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. | 2013 | Cardiol J | pmid:23788300 |
| Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
| Anastasilakis AD et al. | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23788684 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Kato R et al. | Gap-junction-mediated communication in human periodontal ligament cells. | 2013 | J. Dent. Res. | pmid:23677649 |
| Weng CH et al. | [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23596799 |
| Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
| Liu CG et al. | [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:24517065 |
| Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
| Lazzerini PE et al. | Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. | 2013 | Joint Bone Spine | pmid:22999910 |
| Feng ZY et al. | Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. | 2013 | Mol Med Rep | pmid:24126801 |
| Wang X et al. | Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. | 2013 | Chin. J. Traumatol. | pmid:24103822 |
| Lotinun S et al. | Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. | 2013 | J. Clin. Invest. | pmid:23321671 |
| Saki F et al. | Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. | 2013 | J. Bone Miner. Res. | pmid:23322328 |
| Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
| Deng YH et al. | The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. | 2013 | Endocrine | pmid:22798246 |
| Pereira AC et al. | Histomorphometrical and molecular evaluation of endosseous dental implants sites in humans: correlation with clinical and radiographic aspects. | 2013 | Clin Oral Implants Res | pmid:22092653 |
| Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
| Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
| Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
| Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
| Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
| Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
| Mogelvang R et al. | Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. | 2012 | Am. J. Cardiol. | pmid:22100028 |
| Chung E and Rylander MN | Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. | 2012 | Cell Stress Chaperones | pmid:22116637 |
| Koch FP et al. | Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. | 2012 | Clin Oral Investig | pmid:20938793 |
| Li J et al. | Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. | 2012 | J Biomech | pmid:22119108 |
| Tanaka M et al. | Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF. | 2012 | Bone Marrow Transplant. | pmid:22120987 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
| Ueland T et al. | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. | 2012 | Curr Heart Fail Rep | pmid:22453763 |
| Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
| Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
| Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
| Rodriguez-Lorenzo LM et al. | Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. | 2012 | J Tissue Eng Regen Med | pmid:21800433 |
| Duarte PM et al. | Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. | 2012 | J. Periodontol. | pmid:21859322 |
| Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
| Liu S et al. | Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. | 2012 | Hum. Cell | pmid:22399266 |
| Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
| Zupan J et al. | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. | 2012 | J. Biomed. Sci. | pmid:22380539 |
| Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
| Hudson JB et al. | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. | 2012 | Calcif. Tissue Int. | pmid:22382900 |
| Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
| Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
| Zheleznyak A et al. | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | 2012 | Mol Imaging Biol | pmid:21853370 |
| Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
| Wang JQ et al. | [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. | 2012 | Zhongguo Gu Shang | pmid:23427595 |
| Ohe JY et al. | Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. | 2012 | Clin Oral Investig | pmid:21938481 |
| Chen WH et al. | Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. | 2012 | Chin J Integr Med | pmid:22549392 |
| Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
| Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
| Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
| Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
| Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
| Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
| GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
| Zijlstra WP et al. | Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. | 2012 | J. Orthop. Res. | pmid:22025323 |
| Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
| Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
| Martin CK et al. | Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. | 2012 | Oral Oncol. | pmid:22265717 |
| Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
| Garlet GP et al. | Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. | 2012 | J Endod | pmid:22244633 |
| Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
| Feng Y et al. | AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. | 2012 | Chin. Med. J. | pmid:22964327 |
| Pedersen S et al. | Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. | 2012 | Cardiology | pmid:22964478 |
| Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
| Cauley JA | Commentary: A single biomarker in a complex metabolic pathway. | 2012 | Int J Epidemiol | pmid:22933649 |
| Deuell KA et al. | RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. | 2012 | J. Vasc. Res. | pmid:22948607 |
| Li F et al. | Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. | 2012 | Fitoterapia | pmid:22951288 |
| Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
| Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
| Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
| Zhao N et al. | Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22196183 |
| Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
| Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
| Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
| Li YL and Wang H | [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. | 2012 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:22989431 |
| Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
| Xu Y et al. | [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803436 |
| Zhu XF et al. | [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803437 |
| Nyrnes A et al. | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. | 2012 | Gend Med | pmid:23046763 |
| Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
| Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
| Kleyer A et al. | Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. | 2012 | J. Bone Miner. Res. | pmid:22806960 |
| Wang C et al. | Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. | 2012 | J. Bone Miner. Res. | pmid:22807154 |
| Poerschke RL et al. | Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012 | J. Biochem. Mol. Toxicol. | pmid:22807314 |
| Chandran V | Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. | 2012 | J Rheumatol Suppl | pmid:22751596 |
| Belibasakis GN and Bostanci N | The RANKL-OPG system in clinical periodontology. | 2012 | J. Clin. Periodontol. | pmid:22092994 |